Trump, tariffs
Digest more
Top News
Overview
Impacts
USA TODAY |
The stock market bounced back yesterday as President Donald Trump paused his reciprocal tariffs for 90 days.
U.S. News & World Report |
the president pulled back from the import taxes that he had imposed on many U.S. trading partners
U.S. News & World Report |
Economists have warned that U.S. consumers are likely to face higher prices on everything from sneakers to wine as a result of the trade war.
Read more on News Digest
“The Erie Regional Chamber is frustrated by the financial pressure building due to economic uncertainty at the federal level, which IRG cited as the reason to cancel plans for its Erie plastics recycling plant project," Brandon Mendoza, CEO of the Erie Regional Chamber and Growth Partnership, said in a statement.
Though Trump paused tariffs on many countries, tensions between the U.S. and China, the two largest economies, only escalated after Trump raised them on China to 145%.
1hon MSN
NCLA has not yet responded to a request for comment on whether it will expand its lawsuit to include Trump’s more recent round of tariffs, which have escalate
Explore more
"Queasy" investors played a part in President Donald Trump's decision to postpone some tariffs. Wall Street is still worried about the economic fallout.
Former U.S. Treasury Secretary Janet Yellen said on Thursday that the threat of financial instability prompted by falling prices for U.S. Treasury debt in recent days likely influenced President Donald Trump's decision to reverse course and partially pause his tariff campaign.
1hon MSN
Trump was ultimately unable to stand up to the growing chorus of CEOs condemning his administration’s tariff agenda.
Donald Trump paused some tariffs from going into effect Wednesday, sending ripples through the business community.
Trump’s fast-changing tariffs policy has created stressful uncertainty for small businesses that sell on Amazon and other sites and face increased costs.
14hon MSN
Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and even a stall in research and development.